The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge. (HomeCoMe)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01897870|
Recruitment Status : Completed
First Posted : July 12, 2013
Last Update Posted : February 23, 2016
|Condition or disease||Intervention/treatment||Phase|
|Adverse Drug Event Readmission Patient Compliance||Behavioral: HomeCoMe-program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||150 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||The Effect of a Home-based Community Pharmacist-led Medication Management Program (HomeCoMe-program) Complementary to an In-hospital Medication Reconciliation Program on Drug-related Problems Post-discharge: A Prospective Cohort Study.|
|Study Start Date :||November 2013|
|Actual Primary Completion Date :||February 2016|
|Actual Study Completion Date :||February 2016|
Experimental: HomeCoMe-program group
the arm receiving the pharmacist home visit
A home visit by patients own community pharmacist within seven days after hospital discharge. The community pharmacist will perform a semi-structured interview on (1) use of the prescribed medication, (2) ADEs, (3) adherence issues, by (A) assessing patient's needs and concerns around his pharmacotherapy, (B) identifying and solving obstacles for medicines intake, (C) checking on the need for a compliance aid, (D) collecting spare medication and finally (4) knowledge on medication use, when to take which medicine and why, and medication changes made during the hospitalisation.
- Identifying and solving adverse drug events (ADEs) and other drug-related problems (DRPs) post-discharge [ Time Frame: within 7 days post-discharge ]
The total number of assessed and solved ADEs post-discharge will be measured. Assessing and solving ADEs takes place during the pharmacist home visit.
Using START-STOPP criteria on patients medication records, ADEs will also be compared between the intervention and usual care group.
- Improvement of adherence to medication at hospital discharge [ Time Frame: up to 6 months after discharge ]The "medication possession ratio" will be calculated retrospectively from pharmacy dispensing data after 6 months to investigate patient's adherence and compared between the intervention and control group.
- Patient assessment of medication knowledge at time of home visit [ Time Frame: within 7 days after discharge ]At time of the home visit patients are asked about their knowledge (e.g. indication, dose regime, etc) regarding the medication they are taking. Knowledge is scored and lack of knowledge is solved by teaching the patient.
- Types of interventions made at the pharmacist home visit [ Time Frame: within 7 days after discharge ]The types of intervention the pharmacist works on during the 7 day follow-up home visit are assessed.
- Patient satisfaction with the pharmacist home visit [ Time Frame: Immediately after receiving the home visit ]The satisfaction survey consists of 13 interview questions, where the subject subjectively scores each question on a four-point scale, developed specifically for this study.
- Assessment of patient reported health rating [ Time Frame: at 14 days after discharge ]Patient are asked by telephone to report their health on a scale from 1 (worst imaginable health) to 10 (best imaginable health). Number are compared between the intervention and control group.
- General practitioners satisfaction with the pharmacist home visit [ Time Frame: Immediately after the home visit is executed ]The satisfaction survey consists of 13 interview questions, where the subject subjectively scores each question on a four-point scale, developed specifically for this study.
- Assessment of patient reported health rating [ Time Frame: at 42 days after discharge ]Patient are asked by telephone to report their health on a scale from 1 (worst imaginable health) to 10 (best imaginable health). Number are compared between the intervention and control group.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01897870
|Almere, Flevoland, Netherlands, 1315RA|
|Principal Investigator:||Marcel L Bouvy, Prof, PharmD, PhD||UIPS|